$0.0001
+0 (+0%)
At Close: Jun 03, 2026
NEW YORK--(BUSINESS WIRE)---- $SESN--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York o
SESEN BIO SHAREHOLDERS: October 18, 2021 Filing Deadline in Class Action – Contact Lieff Cabraser
01:41pm, Friday, 03'rd Sep 2021
SAN FRANCISCO--(BUSINESS WIRE)---- $SESN #InvestmentFraud--SESEN BIO SHAREHOLDERS: October 18, 2021 Filing Deadline in Class Action – Contact Lieff Cabraser
New York, New York--(Newsfile Corp. - September 3, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Sesen Bio, Inc. ("Sesen Bio" or the
SHAREHOLDER ALERT: ITRM SESN SPPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
05:40am, Friday, 03'rd Sep 2021
NEW YORK, NY / ACCESSWIRE / September 3, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered
Pomerantz Law Firm Announces the Filing of a Class Action Against Sesen Bio, Inc. and Certain Officers - SESN
08:37pm, Thursday, 02'nd Sep 2021
New York, New York--(Newsfile Corp. - September 2, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN) and
Sesen Shareholder Alert
06:17pm, Thursday, 02'nd Sep 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp
SHAREHOLDER ALERT: PLL LIVE SESN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
05:45am, Thursday, 02'nd Sep 2021
NEW YORK, NY / ACCESSWIRE / September 2, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered
New York, New York--(Newsfile Corp. - September 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities
San Francisco, California--(Newsfile Corp. - September 1, 2021) - Hagens Berman urges Sesen Bio, Inc. (NASDAQ: SESN) investors with losses in excess of $250,000 to submit your losses now. Class Perio
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sesen Bio, Inc. (SESN)
11:00am, Wednesday, 01'st Sep 2021
LOS ANGELES, Sept. 1, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming October 18, 2021 deadline to file a lead plaintiff motion in the class action file
Pomerantz Law Firm Announces the Filing of a Class Action Against Sesen Bio, Inc. and Certain Officers - SESN
10:17pm, Tuesday, 31'st Aug 2021
NEW YORK, Aug. 31, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN) and certain of its offi
DEADLINE: Sesen Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Sesen Bio Class Action Lawsuit - SESN
08:05pm, Tuesday, 31'st Aug 2021
San Diego, California--(Newsfile Corp. - August 31, 2021) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sesen Bio, Inc. (NASDAQ: SESN) securities between December 21, 20
New York, New York--(Newsfile Corp. - August 31, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
NEW YORK, Aug. 31, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for th
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
02:00pm, Tuesday, 31'st Aug 2021
August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New molecular entity approvals
Sign In
Buy CARM